Ctmx shares
WebMar 28, 2024 · The company’s shares closed last Monday at $1.79. According to TipRanks.com, Darout is a 4-star analyst with an average return of 7.4% and a 36.5% success rate. Darout covers the Healthcare... WebGet the latest CytomX Therapeutics Inc (CTMX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …
Ctmx shares
Did you know?
WebApr 14, 2024 · The consensus estimate for Berry’s current full-year earnings is $0.81 per share. Capital One Financial also issued estimates for Berry’s Q3 2024 earnings at $0.21 EPS, Q4 2024 earnings at $0. ... WebApr 14, 2024 · A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CTMX. UBS Group AG grew its stake in CytomX …
WebCytomX Therapeutics Inc (CTMX) Stock Price Today, News, Quotes, FAQs and Fundamentals 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. CTMX CytomX Therapeutics Inc 2,597 $1.54 $0.03 (1.99%) Today Market Cap $100M Volume (M) 506,367.00 52-Wk High $3.02 52-Wk Low $1.17 About Feed Sentiment … WebApr 14, 2024 · Peak Bio, Inc. (NASDAQ:PKBO – Get Rating) shares traded down 3.5% during mid-day trading on Thursday . The company traded as low as $0.58 and last traded at $0.58. 270 shares changed hands ...
WebApr 14, 2024 · Shares of NASDAQ:CTMX opened at $1.73 on Friday. CytomX Therapeutics has a 12 month low of $1.17 and a 12 month high of $3.02. The business’s 50 day simple moving average is $2.01 and its 200 ... WebView the latest CytomX Therapeutics Inc. (CTMX) stock price, news, historical charts, analyst ratings and financial information from WSJ.
WebApr 13, 2024 · CytomX Therapeutics (NASDAQ:CTMX – Get Rating) and Stoke Therapeutics (NASDAQ:STOK – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, profitability, valuation and …
phillip holtfreterWebIn last trading session, CytomX Therapeutics Inc. (NASDAQ:CTMX) saw 1.36 million shares changing hands with its beta currently measuring 0.45. Company’s recent per share … phillip hoose duetWebApr 14, 2024 · Mizuho decreased their target price on shares of CytomX Therapeutics from $4.00 to $2.00 and set a “neutral” rating for the company in a research note on Tuesday, … phillip hoose duet reviewsWebJan 5, 2024 · Updates CTMX share movement after hours. CytomX Therapeutics ( NASDAQ: CTMX ) and Moderna ( NASDAQ: MRNA ) have entered into a collaboration … phillip hoose biographyWebEarnings Per Share: The trailing 12 months EPS from total operations is the bottom line income after all expenses, divided by the weighted average number of common shares … tryon vehicle titling trustWebApr 29, 2024 · CytomX Therapeutics Shares Outstanding CytomX Therapeutics Inc (CTMX) CytomX Therapeutics Shares Outstanding: 66.23M for Feb. 28, 2024 Historical Shares … tryon urgent \u0026 family careWebApr 13, 2024 · CytomX Therapeutics Inc. CTMX, +7.19% shares soared more than 50% in the extended session Thursday after the small biotech company announced a … phillip hornby